RANK Ligand Inhibitor
5 drugs across 2 manufacturers|0 Generic,5 Brand
The RANK Ligand Inhibitor class contains 5 NDCs from 2 manufacturers (0 generic, 5 brand), at an average NADAC of $1854.03 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
5
0G / 5B
Manufacturers
2
Avg $1854.0314/unit
Avg 7d Change
-0.01%
Across 3 drugs with changes
7d Activity
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the RANK Ligand Inhibitor class?
The RANK Ligand Inhibitor class contains 5 NDCs from 2 manufacturers — 0 generic and 5 brand products.
What is the average price of RANK Ligand Inhibitor drugs?
The average NADAC for the RANK Ligand Inhibitor class is $1854.0314 per unit across 5 NDCs.
Which manufacturers make RANK Ligand Inhibitor drugs?
2 manufacturers make drugs in the RANK Ligand Inhibitor class. Ranked by number of NDCs, the largest are Amgen Inc. (4), Sandoz Inc. (1).
How has RANK Ligand Inhibitor pricing changed recently?
Over the past 7 days, 1 NDC in this class rose and 2 fell, with a class-wide average change of -0.0%.
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XGEVA 120 MG/1.7 ML VIAL denosumab | $2001.5168 per ML | — |
XGEVA 120 MG/1.7 ML VIAL denosumab | $2001.5168 per ML | — |
PROLIA 60 MG/ML SYRINGE denosumab | $1864.6339 per ML | -0.03% |
PROLIA 60 MG/ML SYRINGE denosumab | $1864.6339 per ML | -0.03% |
JUBBONTI 60 MG/ML SYRINGE denosumab | $1537.8556 per ML | +0.02% |